IRIDEX CORP (IRIX)
$0.71-$0.00 (-0.58%) Today
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 7 | 16,639 | $16K |
| Grant or award | 5 | 600,000 | |
| Tax withholding / forfeiture | 2 | 6,681 | |
| Other acquisition / disposition | 1 | 111,997 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
97 Form 4 filings on record, the earliest from Nov 8, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| William M. Moore | Open-market purchase | Common Stock | 20,000 | $0.97 | $19K | |
| William M. Moore | Open-market purchase | Common Stock | 10,000 | $0.96 | $10K | |
| William M. Moore | Open-market purchase | Common Stock | 20,000 | $0.97 | $19K | |
| Yu-Hao Chen | Grant or award | Common Stock (right to buy) | 53,000 | $0.00 | - | |
| Yu-Hao Chen | Grant or award | Common Stock (right to buy) | 15,000 | $0.00 | - | |
| Patrick Mercer - Officer | Grant or award | Common Stock | 33,370 | $0.94 | $31K | |
| Patrick Mercer - Officer | Grant or award | Common Stock (right to buy) | 111,240 | $0.00 | - | |
 Scott Shuda | Grant or award | Common Stock (right to buy) | 53,000 | $0.00 | - | |
| Romeo R. Dizon - Officer | Grant or award | Common Stock | 22,500 | $0.94 | $21K | |
| Romeo R. Dizon - Officer | Grant or award | Common Stock (right to buy) | 75,000 | $0.00 | - | |
 Beverly A. Huss | Grant or award | Common Stock (right to buy) | 53,000 | $0.00 | - | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 245 | $0.97 | $236 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 500 | $0.99 | $495 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 335 | $0.98 | $327 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 1,500 | $0.97 | $1K | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 100 | $1.00 | $100 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 100 | $0.99 | $99 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 200 | $0.99 | $197 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 200 | $0.95 | $190 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 100 | $1.00 | $100 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 100 | $1.00 | $100 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 100 | $1.01 | $101 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 100 | $1.00 | $100 | |
| Patrick Mercer - Officer | Tax withholding / forfeiture | Common Stock | 14,310 | $0.99 | $14K | |
| William M. Moore | Open-market purchase | Common Stock | 15,000 | $1.10 | $17K | |
| William M. Moore | Open-market purchase | Common Stock | 2,500 | $1.00 | $3K | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 460 | $1.10 | $506 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 100 | $1.15 | $115 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 755 | $1.12 | $846 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 450 | $1.09 | $491 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 100 | $1.16 | $116 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 100 | $1.15 | $115 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 100 | $1.15 | $115 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 193 | $1.15 | $222 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 100 | $1.19 | $119 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 100 | $1.16 | $116 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 100 | $1.20 | $120 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 100 | $1.17 | $117 | |
| William M. Moore | Open-market purchase | Common Stock | 290 | $1.24 | $360 | |
| William M. Moore | Open-market purchase | Common Stock | 19,710 | $1.21 | $24K | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 500 | $1.30 | $650 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 3,407 | $1.22 | $4K | |
| Patrick Mercer - Officer | Open-market purchase | Common Stock | 46 | $1.15 | $53 | |
| Patrick Mercer - Officer | Open-market purchase | Common Stock | 3,000 | $1.30 | $4K | |
| Patrick Mercer - Officer | Open-market purchase | Common Stock | 4,500 | $1.29 | $6K | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 625 | $1.22 | $763 | |
| Romeo R. Dizon - Officer | Open-market purchase | Common Stock | 2,000 | $1.30 | $3K |
This is as far as the anonymous view goes. Create a free account for all 97 IRIX filings on record.
IRIDEX CORP (IRIX) had 11 insider filings in the last 90 days, with the most recent on 2026-08-24. The full record for IRIX runs to 97 Form 4 filings, the earliest from 2024-11-08. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
7 insider purchases of IRIX were filed in the last 90 days, totaling $16K.
No insider sales of IRIX were filed in the last 90 days.
This page tracks IRIX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add IRIX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
